October 13, 2014
CBS News interviews Chinazo Cunningham, M.D., M.S., about the growing problem of opioid painkiller abuse and addiction. Dr. Cunningham explains why opioid abuse has increased significantly in recent years, her research on bias on the part of doctors in prescribing and monitoring opioids, and how Einstein has a structured curriculum to teach future doctors how to treat addition. Dr. Cunningham is professor of medicine and family and social medicine at Einstein and associate chief of the division of general internal medicine at Montefiore Medical Center.
Dr. Cunningham's ProfileMore coverage on Dr. Cunningham
October 12, 2014
CBSNews.com features Alyson Moadel-Robblee, Ph.D., and her BOLD Buddy Program, which pairs patients receiving cancer treatment with companions and provides phone support. The program, hosted at the Montefiore Einstein Center for Cancer Care, is funded by the Avon Foundation and EIF-Revlon Run Run/Walk for Women's Cancers. Dr. Moadel-Robblee is associate professor of clinical epidemiology & population health and of clinical medicine at Einstein and director of the psychosocial oncology program at the Albert Einstein Cancer Center.
Dr. Moadel-Robblee's ProfileMore coverage on Dr. Moadel-Robblee
October 6, 2014
WABC-TV interviews John Condeelis, M.D., about his imaging research that is helping to explain how cancer spreads from the primary tumor. Dr. Condeelis and his team found that normal immune cells, called macrophages, aid the tumor cells in cancer metastasis by directing the tumor cells toward blood vessels. By better understanding this process at the patient level, doctors can more accurately assess which patients need aggressive treatments and which patients can be spared those treatments. Dr. Condeelis is professor and co-chair of anatomy and structural biology and co-director of the Gruss Lipper Biophotonics Center, and the Judith and Burton P. Resnick Chair in Translational Research at Einstein.
Dr. Condeelis' ProfileMore coverage on Dr. Condeelis
October 6, 2014
The New York Times features new research by Elina Jerschow, M.D., that found medications are the cause of most fatal allergic reactions. Dr. Jerschow notes that antibiotics and radiocontrast agents used in imaging studies are the two top medicines responsible for allergic deaths. Dr. Jerschow is assistant professor of medicine at Einstein and director of the Drug Allergy Center at Montefiore Medical Center.
More CoverageDr. Jerschow's ProfileMore coverage on Dr. Jerschow
October 2, 2014
The New Yorker reports on the growing concern about concussions in soccer. Michael Lipton, M.D., Ph.D., discusses his research on head injury in amateur players from heading. Dr. Lipton’s studies have found that repeated, deliberate sub-concussive hits from heading damages the brains of players and leads to cognitive and memory problems. Dr. Lipton is associate professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein and medical director of MRI services at Montefiore Medical Center.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
September 22, 2014
Time features research led by Sophie Molholm, Ph.D., suggesting that brain scans measuring how quickly children process sensory information could be used to diagnose autism. The study found the degree to which a child abnormally processed sights and sounds was directly correlated to the severity of autism symptoms. Dr. Molholm is associate professor in the Dominick P. Purpura Department of Neuroscience and of pediatrics and the Muriel and Harold Block Faculty Scholar in Mental Illness.
More CoverageDr. Molholm's ProfileMore coverage on Dr. Molholm
September 18, 2014
Wall Street Journal interviews Judy Wylie-Rosett, Ph.D., about research that suggests artificial sweeteners may raise blood sugar levels by altering the body’s gut bacteria. Dr. Wylie-Rosett notes that the study is important since it is the first to examine how gut microbes contribute to processing real and fake sugars. Dr. Wylie-Rosett is head of the division of health promotion and nutrition research, and professor of epidemiology & population health and of medicine at Einstein.
Dr. Rosett's ProfileMore coverage on Dr. Rosett
September 15, 2014
Nature interviews Dean Hosgood, Ph.D., M.P.H, about his research on the environmental and genetic factors that lead to high rates of lung cancer in non-smoking Asian women. Dr. Hosgood notes that as smoking decreases, other factors will become a larger proportion of lung cancer cases, so investigating this phenomenon can help the wider population. Dr. Hosgood is assistant professor of epidemiology & population health.
Dr. Hosgood's Profile
September 9, 2014
CBSNews.com interviews Lisa Shulman, M.D., about a promising autism intervention program that helped resolve autism behaviors in the majority of 7-to-15-month-olds studied. Dr. Shulman calls the study “groundbreaking” and also outlines a few key behaviors parents should look out for, such as fixating for long periods on objects rather than faces. Dr. Shulman is associate professor of clinical pediatrics and director of infant and toddler services at Einstein’s Children’s Evaluation and Rehabilitation Center and an attending physician at The Children’s Hospital at Montefiore.
More CoverageDr. Shulman's ProfileMore coverage on Dr. Shulman
September 4, 2014
The Washington Post interviews Richard Lipton, M.D., about why more women than men develop Alzheimer’s disease. Research from Dr. Lipton’s Einstein Aging Study found that women, ages 70 to 79, were more than twice as likely to develop Alzheimer’s or other forms of dementia as men of the same age, but that after the age of 80 the risk is similar for both genders. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
September 2, 2014
New York Times interviews Kartik Chandran, Ph.D., about new research that found the experimental Ebola drug ZMapp was successful in treating monkeys infected with the virus. The drug was used to treat two American aid workers infected during the current West African outbreak. Dr. Chandran notes the preliminary results were astounding as following treatment all the monkeys were healthy. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology
Dr. Chandran's ProfileMore coverage on Dr. Chandran
August 29, 2014
New York Times interviews Kami Kim, M.D., about research that finds the parasite Toxoplasma gondii can manipulate the behavior of its host by switching on genes in brain cells. Research by Dr. Kim has found that a number of pathogens, including leprosy, appear to use DNA methylation to turn genes on and off in the animal it infects. Dr. Kim is professor medicine, of microbiology & immunology and of pathology.
Dr. Kim's ProfileMore coverage on Dr. Kim
August 27, 2014
CBSNews.com interviews Michael Lipton, M.D., Ph.D., about the FDA consumer alert for dietary supplements that falsely claim to prevent or cure concussions. Dr. Lipton notes that such claims may lead people to be less careful than they should and that the best way to prevent a concussion is to not have a head injury. Dr. Lipton is associate professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein and medical director of MRI services at Montefiore Medical Center.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
August 19, 2014
NY1 interviews Jonathan Lai, Ph.D., about his research on Ebola that focuses on developing antibodies to use as a possible treatment for all five strains of the virus. Dr. Lai notes that so far his lab has discovered antibodies that have proven protective in mice against the Sudan strain of the Ebola virus, but more research is required. Dr. Lai is associate professor of biochemistry.
More CoverageDr. Lai's ProfileMore coverage on Dr. Lai
August 15, 2014
USA Today interviews Belinda Ostrowsky, M.D., about rapid detection tests for Ebola that are in development. The fastest reliable tests for Ebola currently take about three days, which can delay treatment. Dr. Ostrowsky notes that any rapid detection method would benefit patients and healthcare providers. Dr. Ostrowsky is associate professor of clinical medicine at Einstein and director of the Einstein-Montefiore Antibiotic Stewardship Program.
Dr. Ostrowsky's ProfileMore coverage on Dr. Ostrowsky